Herbert G. Markley, MD, FAAN, FAHS, Director is a Board-certified neurologist and full-time headache specialist. He is a graduate of the University of Maryland School of Medicine, then did additional training in Internal Medicine at Johns Hopkins University, in Neurology at McGill University (Montreal Neurological Institute) and in Neuropharmacology at the University of Colorado.
He has been in Worcester, Massachusetts since 1983 where he is currently the Director of the New England Regional Headache Center.
He is an Affiliate and former Associate Professor in the Department of Neurology at the University of Massachusetts Medical School. He is also board-certified in the new specialty of Headache Medicine, as well as being a long-time Fellow of the American Academy of Neurology and member of its Section on Headache and Facial Pain. He is a founding member of the Headache Cooperative of New England, formerly the Treasurer and Vice-President, currently a Member of the Board of Directors.
In the past, he served as the Co-Director of Education for The American Association for the Study of Headache. He is a Fellow of the American Headache Society, as well as a member of the National Headache Foundation, International Headache Society and the World Cervicogenic Headache Society.
Dr. Markley's research activities include clinical trials of new drugs for headache management, as well as the development of new and innovative treatments for chronic headache, including surgical procedures and electrical neurostimulation.
He has been selected three times for "The Best Doctors in America." Other awards include the Glaxo "Migraine Pioneer" award for initial clinical trials on Imitrex. He has consulted for such pharmaceutical companies as Merck Laboratories, AstraZeneca, Abbott, Bristol-Myers-Squibb, Ortho McNeil, Novartis, Johnson and Johnson, GlaxoSmithKline, St. Jude Medical and Advanced Bionics. He serves on Advisory Boards and Speakers' Bureaus of some of these companies.
Continue to Our Team.